Showing results (461-470 of 600) with videos related to

Sort By:
Pageof 60
Anais Da Academia Brasileira De Ciencias|July 8, 2026
Conservation, diversity, and evaluation of Cassava landraces for northern Mato GrossoAuana Vicente Tiago, Fernando S Rossi, Eliane Cristina M DE Pedri, et al.
Cytometry|July 15, 1999
Quantitative measurement of mast cell degranulation using a novel flow cytometric annexin-V binding assayS D Demo, E Masuda, A B Rossi, et al.
Dermatology and Therapy|June 18, 2021
Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis and Prior Use of Systemic Non-Steroidal Immunosuppressants: Analysis of Four Phase 3 TrialsChristopher Griffiths, Marjolein de Bruin-Weller, Mette Deleuran, et al.
Medical Physics|April 25, 2001
Intensity modulated proton therapy: a clinical exampleA J Lomax, T Boehringer, A Coray, et al.
European Journal of Cancer Care|August 24, 2017
Efficacy of a global supportive skin care programme with hydrotherapy after non-metastatic breast cancer treatment: A randomised, controlled studyF Dalenc, V Ribet, A B Rossi, et al.
The British Journal of Dermatology|August 14, 2019
Laboratory safety of dupilumab in moderate-to-severe atopic dermatitis: results from three phase III trials (LIBERTY AD SOLO 1, LIBERTY AD SOLO 2, LIBERTY AD CHRONOS)A Wollenberg, L A Beck, A Blauvelt, et al.
The British Journal of Dermatology|June 2, 2020
Assessing the need for routine safety testing for patients being treated with dupilumab for moderate-to-severe atopic dermatitisA Wollenberg, L A Beck, A Blauvelt, et al.
Ecology and Evolution|July 25, 2018
Rivers shape population genetic structure in <i>Mauritia flexuosa</i> (Arecaceae)Nilo L Sander, Francisco Pérez-Zavala, Carolina J Da Silva, et al.
The British Journal of Dermatology|December 4, 2023
Burden of atopic dermatitis in paediatric patients: an international cross-sectional studyStephan Weidinger, Eric L Simpson, Jonathan I Silverberg, et al.
Journal of the American Academy of Dermatology|March 6, 2020
Dupilumab treatment results in early and sustained improvements in itch in adolescents and adults with moderate to severe atopic dermatitis: Analysis of the randomized phase 3 studies SOLO 1 and SOLO 2, AD ADOL, and CHRONOSJonathan I Silverberg, Gil Yosipovitch, Eric L Simpson, et al.
Pageof 60